Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 1,311

Document Document Title
WO/1986/003750A1
A method for preparing a stable aerosol formulation of beclomethasone dipropionate in which the steroid is contacted with an alcohol containing 1 to 5 carbon atoms to form a crystalline solvate therewith, the crystalline material so form...  
WO/1986/000907A1
A process for the manufacture of 6alpha-methyl steroids having general formula (I) in which X is a hydroxy group and Y a hydrogen atom, or X and Y are together a carbon-carbon bond and R1 is a cyano group, an acetyl group or an alkanoylo...  
JP2017206563A
[Subject] A cure for a neuromuscular disease like myotrophia dystonica is provided. [Means for Solution] The present invention relates to a compound and a method which may be useful as a cure for a neuromuscular disease like myotrophia d...  
JP2017530184A
In the col Texolone derivative of a certain kind in which the present invention has formula (I), and a row, Use of the compound as an anticancer active ingredient for therapeutic [a precancerous pathological change, a different formation...  
JP2017530171A
In the col Texolone derivative of a certain kind in which the present invention has formula (I), and a row, Use of the compound as an anticancer active ingredient for therapeutic [a precancerous pathological change, a different formation...  
JP2017526741A
This indication provides the compound denoted by formula (I), and its medicine constituent. It is found out that the compound denoted by formula (I) combines a Bromo domain and/or Bromo domain content protein (for example, Bromo and spec...  
JP6194335B2  
JP2017132817A
[Subject] Cancer specific type, for example, primary and metastatic cancer, and the conventional Chemotherapy Offer of a method of treating and preventing to law cancer which is recalcitrance or tolerance. [Means for Solution] Compound 4...  
JP2017521459A
The present invention relates to the method for preparing the new steroid compound of formula (I), and it, and the constituent containing these compounds. [Formula 1]  
JP6174645B2  
JP2017516851A
The present invention relates to a compound and its therapeutic use, especially the use for improving the quality of the muscles in a mammal. In detail, the present invention can improve the quality of the muscles in the mammal of sarcop...  
JP2017105827A
[Subject] A subject of this application is providing the method of halogenating a carbon content compound for having C-H combination of sp3. [Means for Solution] The method of halogenating a carbon content compound for having C-H combina...  
JP2016526011A5  
JP6108944B2  
JP2016519111A5  
JP2017019845A5  
JP2016503793A5  
JP2017019845A
To provide a process for reducing the particle size of an active pharmaceutical ingredient (API) while maintaining its polymorphic form.The process comprises the step of processing the active pharmaceutical ingredient by cavitation at el...  
JP2016540001A
In the present invention, the various solid forms of a specific steroid-like compound, the manufacturing method of those, and its use are provided. In one mode, the crystal form of the steroid-like compound, its manufacturing method, and...  
JP2016190881A
[Subject] Offer of an ornamentation medicine for using it in Liposome nano particles. [Means for Solution] This specification is provided with a medicine derivative suitable for making a Liposome nano particle career fill up. In some des...  
JP2016180004A
[Subject] Provide new 19- Nor steroid for treating a progesterone dependence state, and directions for use for the same. [Means for Solution] The theme of the present invention is related with a field of medical treatment of a hormonal d...  
JP2016526011A
Especially the nanoparticle containing a chemotherapeutic drug and an antiinflammatory agent has cytotoxicity to prostate cancer cells. This indication is divided and indicates the nanoparticle (NP) platform which has the capability to s...  
JP2016523889A
The present invention provides the method for preparing the intermediate for preparing Avila Theron, Avila Theron, and its intermediate. As an intermediate, the compound of formula (IV) (R expresses a hydroxy blocking group among a formu...  
JP2016519111A
Conjugate including interleukin 4 (IL4) and a specific association member is indicated. Preferably, it combines with the extra-cellular-matrix ingredient relevant to new organism multiplication and/or a blood vessel rebirth, and the spec...  
JP2016106122A
[Subject] Provide 19* Knoll neuroactive steroid and directions for use for the same. [Means for Solution] Effect with the superior present invention, the pharmacodynamic (PK) characteristic, oral bioavailability, Tablet-ized aptitude (fo...  
JP2016510753A
[Subject] The present invention explains the new single medicine substance formed by the combination of the antibiotic with the steroid medicine through a linker. [Means for Solution] In the case of topical application to an eye, the con...  
JP2016505038A
The compound and constituent of 11beta* hydroxy steroid with the new present invention, And medical supplies for preventing or reversing damage to the mitochondria in humans or an animal object, Those application as medical supplies for ...  
JP2016503793A
The present invention relates to the Neurotropic activity 19* alkoxy *17* substitution steroid for, using it for a GABA function and the disposal of an obstacle which is related in it being active as anesthetic generally indicated here, ...  
JP2016014045A
To provide an enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydro derivatives.The present invention refers to an enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydro de...  
JP5839770B2  
JP5830005B2  
JP2014528485A5  
JP2015187156A
To provide methods of treating and preventing a specific cancer, for example, a primary or metastatic cancer and a cancer refractory or resistant to conventional chemotherapy.A medicine for the treatment or prevention of multiple myeloma...  
JPWO2013122112A
A prodrug of 2* nitroglycerine *1* imidazole propionic acid and a therapeutic active organic compound which has an amino group, an annular amino group, or a hydroxyl machine in a molecule, and a prodrug as which a therapeutic organic com...  
JPWO2013122112A1
2−ニトロ−1−イミダゾールプロピオン酸 と分子中にアミノ基、環状アミノ基またはヒ ドロキシル基を持つ治療的活性有機化合物の プロドラッグ、特に、治療的有機化合物...  
JP5646992B2  
JP5631203B2  
JP2014528485A
Inside of :type by which a 3 concerning formula (I) and (III) and 3* 2 substitution 19* Knoll * steroid compound is provided in this specification, R1R2R3R3'R4R6aR6aR11aAnd R11bIt is as defining in は and this specification. The compoun...  
JP2014196358A
To provide modified drugs for use in liposomal nanoparticles.Drug derivatives are provided herein which are suitable for loading into liposomal nanoparticle carriers. In some preferred aspects, the derivatives comprise a poorly water-sol...  
JP2014500316A5  
JP2014101382A
To provide modified drugs for use in liposomal nanoparticles.Drug derivatives are provided herein which are suitable for loading into liposomal nanoparticle carriers. In some preferred aspects, the derivatives comprise a poorly water-sol...  
JP5473029B2  
JP2014508784A
This application indicates those use (independent and combined use) in the medical treatment of 17beta* hydroxy steroid dehydrogenase (17beta HSD) 1 type, 3 types, 10 type inhibitor, cancer, and other diseases. The estradiol derivative w...  
JP5417562B2  
JP5413836B2  
JP2014500316A
The theme of the present invention is related with the field of the medical treatment of a hormonal dependence disease. The new compound and method for the medical treatment of these diseases are indicated. The embodiment of the present ...  
JP2013163683A
To obtain 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives through an enzymatic process.The present invention refers to an enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives...  
JP5260537B2  
JP5250174B2  
JP5232083B2  

Matches 251 - 300 out of 1,311